SynthesisDeutsches Arzteblatt international2026
Transarterial Embolization in Osteoarthritis of the Knee: Mechanism of Action and Current Results.
Synthesis in Deutsches Arzteblatt international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundApproximately 5.2 million people in Germany suffer from osteoarthritis of the knee. Minimally invasive embolization of the genicular artery (GAE) was first described in 2015. It reduces pathologically altered synovial vascularization in the periarticular tissue and the associated inflammatory processes. It is thought that this can inhibit the disease process and relieve pain in patients with symptomatic osteoarthritis of the knee who do not respond to conservative treatment. In this review, we assess this technique with regard to its safety and efficacy.
methodsThis narrative review is based on pertinent publications (2015-2025) retrieved by a search in the PubMed/Medline and Google Scholar databases for prospective and retrospective clinical studies and meta-analyses.
results25 studies on GAE have appeared since 2015, among them three randomized controlled trials (RCTs) with sham controls (n = 21; n = 59; n = 58). In a small-scale multicenter RCT (n = 21), GAE reduced pain to a markedly greater extent at 1 month compared to controls (VAS difference 50.1 mm, 95% confidence interval [29.0-72.3]; p < 0.01). Two larger RCTs did not reveal any significant additional benefit compared to sham treatment. In the Australian triple-blind RCT (n = 59) the mean improvement in the KOOS pain score at 12 months was higher in the GAE group (41.3% vs 29.4%), but the difference between groups was not significant. In the Dutch RCT (n = 58), the mean improvement in the KOOS pain score at 4 months was 21.4 points [13.9-28.8] after GAE and 18.4 [11.6-25.1] after sham treatment; the intergroup difference of 3 points was not significant ([-7.1 to 13.0], p = 0.31). Adverse events were rare and generally self-limiting.
conclusionBefore-and-after studies showed safe pain relief by GAE, but these findings have not been confirmed by the RCTs that have been carried out to date. Current evidence is mixed. Larger-scale, methodologically robust RCTs are needed so that the efficacy of GAE and its role in the treatment of symptomatic knee osteoarthritis can be reliably evaluated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.